Values as of: 2019-06-18
ETF | Mid-Cap Growth | NYSE Arca
Last Closing
USD 224.26Change
+2.23 (+1.00)%Market Cap
USD 5.61BVolume
0.04MAnalyst Target
N/A
N/A
Verdict
The investment seeks to track the investment results of the S&P MidCap 400 Growth IndexTM, which measures the performance of the mid-capitalization growth sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
Company Website : www.ishares.com
Currency: USD
Country : USA
Inception Date: 24/07/2000
Primary Benchmark: S&P MidCap 400 Growth TR USD
Primary Index: S&P 500 TR USD
Gross Expense Ratio: 0.25%
Management Expense Ratio: 0.24 %
N/A
N/A
| Symbol | Company Name | Allocation |
|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 1.38 % |
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| IWP | iShares Russell Mid-Cap Growth.. | 0.24 % |
-0.14 (-0.13%) |
USD 14.98B |
| VOT | Vanguard Mid-Cap Growth Index .. | 0.07 % |
+0.26 (+0.12%) |
USD 12.34B |
| MDYG | SPDR® S&P 400 Mid Cap Growth .. | 0.15 % |
+0.02 (+0.02%) |
USD 2.87B |
| XMMO | Invesco S&P MidCap Momentum ET.. | 0.39 % |
-0.46 (-0.42%) |
USD 1.60B |
| IVOG | Vanguard S&P Mid-Cap 400 Growt.. | 0.20 % |
+0.10 (+0.10%) |
USD 0.95B |
| RFG | Invesco S&P MidCap 400® Pure .. | 0.35 % |
+0.07 (+0.15%) |
USD 0.33B |
| ETHO | Etho Climate Leadership U.S. E.. | 0.45 % |
+0.04 (+0.07%) |
USD 0.18B |
| IPO | Renaissance IPO ETF | 0.60 % |
-0.28 (-0.74%) |
USD 0.17B |
| CWS | AdvisorShares Focused Equity E.. | 0.68 % |
-0.17 (-0.27%) |
USD 0.14B |
| BFOR | Barron's 400 ETF | 0.65 % |
+0.08 (+0.13%) |
USD 0.14B |
N/A
| Market Performance vs. Industry/Classification (Mid-Cap Growth) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 17.27% | 30% | F | 72% | C | ||
| Dividend Return | 0.63% | 83% | B | 22% | F | ||
| Total Return | 17.90% | 30% | F | 70% | C- | ||
| Trailing 12 Months | |||||||
| Capital Gain | -3.34% | 39% | F | 45% | F | ||
| Dividend Return | 1.25% | 88% | B+ | 21% | F | ||
| Total Return | -2.09% | 50% | F | 41% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 43.77% | 62% | D | 80% | B- | ||
| Dividend Return | 6.68% | 77% | C+ | 22% | F | ||
| Total Return | 50.44% | 62% | D | 77% | C+ | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 8.41% | 67% | D+ | 78% | C+ | ||
| Dividend Return | 9.53% | 61% | D- | 75% | C | ||
| Total Return | 1.12% | 83% | B | 23% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 10.16% | 67% | D+ | 66% | D+ | ||
| Risk Adjusted Return | 93.80% | 83% | B | 84% | B | ||
| Market Capitalization | 5.61B | 95% | A | 84% | B | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
There is nothing we particularly dislike
